Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | Mr. Daniel G. KirbyChief Commercial Officer | -2,44k | 9,01k | Derivative Exercise and Sale | 3,70 | 146,95k | - |
| 2026-05-11 | Mr. Daniel G. KirbyChief Commercial Officer | 7,57k | 0,00 | Derivative Exercise and Retained Stock | - | 146,95k | 5,43% |
| 2026-03-05 | Dr. Friedrich Graf FinckensteinChief Medical Officer | 14,73k | 0,00 | Derivative Exercise and Retained Stock | - | 131,96k | 12,56% |
| 2026-03-05 | Dr. Friedrich Graf FinckensteinChief Medical Officer | -16,52k | 75,66k | Derivative Exercise and Sale | 4,58 | 131,96k | - |
| 2026-03-05 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | 35,74k | 0,00 | Derivative Exercise and Retained Stock | - | 529,54k | 7,24% |
| 2026-03-05 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | -26,76k | 122,54k | Derivative Exercise and Sale | 4,58 | 529,54k | - |
| 2026-03-05 | Dr. Raj K. PuriChief Regulatory Officer | 20,70k | 0,00 | Derivative Exercise and Retained Stock | - | 239,23k | 9,47% |
| 2026-03-05 | Dr. Raj K. PuriChief Regulatory Officer | -18,36k | 84,09k | Derivative Exercise and Sale | 4,58 | 239,23k | - |
| 2026-03-05 | Dr. Igor P. BilinskyCOO | 14,62k | 0,00 | Derivative Exercise and Retained Stock | - | 125,77k | 13,15% |
| 2026-03-05 | Dr. Igor P. BilinskyCOO | -16,63k | 76,16k | Derivative Exercise and Sale | 4,58 | 125,77k | - |
| 2026-03-02 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | 29,28k | 0,00 | Derivative Exercise and Retained Stock | - | 493,80k | 6,30% |
| 2026-03-02 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | -22,81k | 86,45k | Derivative Exercise and Sale | 3,79 | 493,80k | - |
| 2026-03-02 | Dr. Raj K. PuriChief Regulatory Officer | 2,67k | 0,00 | Derivative Exercise and Retained Stock | - | 218,53k | 1,24% |
| 2026-03-02 | Dr. Raj K. PuriChief Regulatory Officer | -2,80k | 10,60k | Derivative Exercise and Sale | 3,79 | 218,53k | - |
| 2026-03-02 | Dr. Igor P. BilinskyCOO | 5,40k | 0,00 | Derivative Exercise and Retained Stock | - | 111,15k | 5,11% |
| 2026-03-02 | Dr. Igor P. BilinskyCOO | -6,90k | 26,16k | Derivative Exercise and Sale | 3,79 | 111,15k | - |
| 2026-03-02 | Dr. Friedrich Graf FinckensteinChief Medical Officer | 5,58k | 0,00 | Derivative Exercise and Retained Stock | - | 117,23k | 4,99% |
| 2026-03-02 | Dr. Friedrich Graf FinckensteinChief Medical Officer | -7,12k | 26,99k | Derivative Exercise and Sale | 3,79 | 117,23k | - |
| 2026-02-24 | Mr. Daniel G. KirbyChief Commercial Officer | 85,84k | 0,00 | Derivative Exercise and Retained Stock | - | 139,38k | 160,30% |
| 2026-02-24 | Mr. Daniel G. KirbyChief Commercial Officer | -34,17k | 129,14k | Derivative Exercise and Sale | 3,78 | 139,38k | - |
| 2026-02-10 | Mr. Daniel G. KirbyChief Commercial Officer | 23,55k | 0,00 | Derivative Exercise and Retained Stock | - | 53,55k | 78,49% |
| 2026-02-10 | Mr. Daniel G. KirbyChief Commercial Officer | -16,45k | 42,77k | Derivative Exercise and Sale | 2,60 | 53,55k | - |
| 2025-12-01 | Dr. Friedrich Graf FinckensteinChief Medical Officer | 6,25k | 0,00 | Derivative Exercise and Retained Stock | - | 111,66k | 5,93% |
| 2025-12-01 | Dr. Friedrich Graf FinckensteinChief Medical Officer | -6,45k | 14,20k | Derivative Exercise and Sale | 2,14 - 2,23 | 111,66k | - |
| 2025-12-01 | Dr. Igor P. BilinskyCOO | 6,06k | 0,00 | Derivative Exercise and Retained Stock | - | 105,74k | 6,07% |
| 2025-12-01 | Dr. Igor P. BilinskyCOO | -6,25k | 13,78k | Derivative Exercise and Sale | 2,14 - 2,23 | 105,74k | - |
| 2025-12-01 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | 29,96k | 0,00 | Derivative Exercise and Retained Stock | - | 464,52k | 6,89% |
| 2025-12-01 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | -22,13k | 48,94k | Derivative Exercise and Sale | 2,14 - 2,23 | 464,52k | - |
| 2025-12-01 | Dr. Raj K. PuriChief Regulatory Officer | 3,00k | 0,00 | Derivative Exercise and Retained Stock | - | 215,86k | 1,41% |
| 2025-12-01 | Dr. Raj K. PuriChief Regulatory Officer | -2,47k | 5,50k | Derivative Exercise and Sale | 2,23 | 215,86k | - |
| 2025-09-02 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | 29,96k | 0,00 | Derivative Exercise and Retained Stock | - | 434,56k | 7,40% |
| 2025-09-02 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | -22,13k | 48,46k | Derivative Exercise and Sale | 2,19 | 434,56k | - |
| 2025-09-02 | Dr. Raj K. PuriChief Regulatory Officer | 3,00k | 0,00 | Derivative Exercise and Retained Stock | - | 212,86k | 1,43% |
| 2025-09-02 | Dr. Raj K. PuriChief Regulatory Officer | -2,47k | 5,40k | Derivative Exercise and Sale | 2,19 | 212,86k | - |
| 2025-09-02 | Dr. Igor P. BilinskyCOO | 6,06k | 0,00 | Derivative Exercise and Retained Stock | - | 99,69k | 6,47% |
| 2025-09-02 | Dr. Igor P. BilinskyCOO | -6,25k | 13,69k | Derivative Exercise and Sale | 2,19 | 99,69k | - |
| 2025-09-02 | Dr. Friedrich Graf FinckensteinChief Medical Officer | 6,25k | 0,00 | Derivative Exercise and Retained Stock | - | 105,41k | 6,30% |
| 2025-09-02 | Dr. Friedrich Graf FinckensteinChief Medical Officer | -6,45k | 14,12k | Derivative Exercise and Sale | 2,19 | 105,41k | - |
| 2025-06-05 | Mr. Daniel G. KirbyChief Commercial Officer | 30,00k | 55,20k | Kauf | 1,84 | 30,00k | - |
| 2025-06-02 | Dr. Raj K. PuriChief Regulatory Officer | 3,00k | 0,00 | Derivative Exercise and Retained Stock | - | 209,85k | 1,45% |
| 2025-06-02 | Dr. Raj K. PuriChief Regulatory Officer | -2,47k | 4,34k | Derivative Exercise and Sale | 1,76 | 209,85k | - |
| 2025-06-02 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | 29,96k | 0,00 | Derivative Exercise and Retained Stock | - | 404,60k | 8,00% |
| 2025-06-02 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | -22,13k | 38,94k | Derivative Exercise and Sale | 1,76 | 404,60k | - |
| 2025-06-02 | Dr. Friedrich Graf FinckensteinChief Medical Officer | 6,25k | 0,00 | Derivative Exercise and Retained Stock | - | 99,16k | 6,72% |
| 2025-06-02 | Dr. Friedrich Graf FinckensteinChief Medical Officer | -6,45k | 11,35k | Derivative Exercise and Sale | 1,76 | 99,16k | - |
| 2025-06-02 | Dr. Igor P. BilinskyCOO | 6,06k | 0,00 | Derivative Exercise and Retained Stock | - | 93,63k | 6,91% |
| 2025-06-02 | Dr. Igor P. BilinskyCOO | -6,25k | 11,00k | Derivative Exercise and Sale | 1,76 | 93,63k | - |
| 2025-06-02 | Mr. Jean-Marc BelleminInsider | 4,33k | 0,00 | Derivative Exercise and Retained Stock | - | 60,53k | 7,70% |
| 2025-06-02 | Mr. Jean-Marc BelleminInsider | -4,46k | 7,86k | Derivative Exercise and Sale | 1,76 | 60,53k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
